Wednesday, August 11, 2021 1:25:00 AM
C20,
I know I sound overly pessimistic, but I've continued to keep and expand my collection of resources and articles. I read them all prior to putting them in place, and what I'm reading is extremely concerning. Now, possibly (hopefully) the reports are "over-blown" concerning the variants (Delta and Lambda and who knows what's developing to overtake them). In any case, we're not equipped to handle this onslaught. It's that simple.
The vaccines can't keep pace with the expanding panoply of variants with the waves arriving with greater frequency.
Now we're about to be hammered as some folks, deny, claim it's their right, etc. Unfortunately, the autocratic countries have an advantage over us in that regard. It's the equivalent of "get the shot or get shot." I don't know what's going to become of our economy and the intricate systems that up-to-this-point cooperate to make it work. The clowns in charge may have dithered too long, and I assume our competitors (China, Russia, Iran, etc.) have (behind the scene) helped to fund/encourage/undermine to make it more likely.
I'll also be very surprised if those same countries haven't gotten samples of LL from the supplies in the Philippines and are already synthesizing/producing it in quantity for their uses. They'll use it themselves and make it a big bargaining chip with others. Meanwhile, over here - we're being BADLY PLAYED!
Sorry, but this REALLY concerns me. I hope, sincerely hope I've gotten this all wrong.
IMO
I know I sound overly pessimistic, but I've continued to keep and expand my collection of resources and articles. I read them all prior to putting them in place, and what I'm reading is extremely concerning. Now, possibly (hopefully) the reports are "over-blown" concerning the variants (Delta and Lambda and who knows what's developing to overtake them). In any case, we're not equipped to handle this onslaught. It's that simple.
The vaccines can't keep pace with the expanding panoply of variants with the waves arriving with greater frequency.
Now we're about to be hammered as some folks, deny, claim it's their right, etc. Unfortunately, the autocratic countries have an advantage over us in that regard. It's the equivalent of "get the shot or get shot." I don't know what's going to become of our economy and the intricate systems that up-to-this-point cooperate to make it work. The clowns in charge may have dithered too long, and I assume our competitors (China, Russia, Iran, etc.) have (behind the scene) helped to fund/encourage/undermine to make it more likely.
I'll also be very surprised if those same countries haven't gotten samples of LL from the supplies in the Philippines and are already synthesizing/producing it in quantity for their uses. They'll use it themselves and make it a big bargaining chip with others. Meanwhile, over here - we're being BADLY PLAYED!
Sorry, but this REALLY concerns me. I hope, sincerely hope I've gotten this all wrong.
IMO
Recent CYDY News
- CytoDyn to Present at the LD Micro Invitational XVI • GlobeNewswire Inc. • 05/15/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 08:32:50 PM
- CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer • GlobeNewswire Inc. • 04/27/2026 12:30:00 PM
- CytoDyn to Host Investor Webcast • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/22/2026 09:21:50 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study • GlobeNewswire Inc. • 04/21/2026 08:10:00 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- CytoDyn to Present at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/08/2026 09:15:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/08/2026 12:30:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 01:35:02 PM
- CytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab • GlobeNewswire Inc. • 03/05/2026 01:30:00 PM
